Hydrocephalus, Normal Pressure: Clinical Trials

63 trials for Hydrocephalus, Normal Pressure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 12 unknown, 11 recruiting, 8 terminated. 26 Not applicable, 3 Phase 3, 2 Phase 2, 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable26Completed 8, Unknown 5, Terminated 4, Active not recruiting 3, Recruiting 3, Not yet recruiting 2, Withdrawn 1
Phase 33Completed 2, Terminated 1
Phase 22Completed 1, Unknown 1
Phase 42Completed 1, Withdrawn 1
Early Phase 11Completed 1

Follow Hydrocephalus, Normal Pressure: new trials by email Literature Review of Hydrocephalus, Normal Pressure trials Research Report on Hydrocephalus, Normal Pressure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland
patients will receive NPH education, primary care physicians (PCPs) will receive professional NPH education, A community health worker will assist PCP - Normal Pressure Hydrocephalus, Hakim Syndrome
Not applicableNot yet recruitingJohns Hopkins Bloomberg School of Public Health6602027-08-012026-05-07
Prediction of Response to Shunt Surgery in Normal Pressure Hydrocephalus Using Radscale and Lumbar Puncture
Idiopathic Normal Pressure Hydrocephalus, Normal Pressure Hydrocephalus
Not yet recruitingAssiut University402026-10-012026-09-22
Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
Intellidrop Automated CSF Drainage System - NPH (Normal Pressure Hydrocephalus)
Not applicableRecruitingUniversity of Texas Southwestern Medical Center102026-05-142026-06-02
Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus
Intervention group "Virtual OFF", Control group (no change in shunt setting) - Normal Pressure Hydrocephalus Patients, Normal Pressure Hydrocephalus
Not applicableNot yet recruitingGöteborg University602025-09-152025-09-15
Analysis of Cerebrospinal Fluid Dynamics in Normal Pressure Hydrocephalus
Cerebrospinal fluid drainge - Normal Pressure Hydrocephalus
Not applicableRecruitingChungnam National University Hospital222025-09-112026-09-21
White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)
Ventriculoperitoneal Shunt (VP), Brain and Skin Biopsy, MRI Brain - Normal Pressure Hydrocephalus
RecruitingImperial College London1002025-03-252026-03-27
The Use of Q-Collar to Increase CSF Drainage in Low-pressure Hydrocephalus Patients
Q-collar - Low Pressure Hydrocephalus
Not applicableWithdrawnUniversity of Kansas Medical Center2024-12-012025-07-08
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
CereVasc eShunt System, VP Shunt - Normal Pressure Hydrocephalus
Not applicableActive not recruitingCereVasc Inc2302024-11-262026-06-25
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Immunohistochemistry and immunofluorescence - Alzheimer Disease, Frontotemporal Dementia
RecruitingUniversidad Autonoma de San Luis Potosí402023-12-202024-12-16
Role of Brain Specific Biomarkers in Hydrocephalus
Lumbar puncture, External lumbar drainage, Ventriculo-peritoneal shunt placement - Hydrocephalus, Normal Pressure, Biochemical Lesions Head Region
CompletedUniversity Hospital Hradec Kralove322023-11-012025-02-21
European Study of Prodromal iNPH
Shunt surgery - Normal Pressure Hydrocephalus, Hydrocephalus
RecruitingJohan Virhammar1402023-11-012026-04-30
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
CODMAN CERTAS Plus Programmable Valve - Hydrocephalus, Hydrocephalus in Children
Active not recruitingIntegra LifeSciences Corporation1602023-01-242026-02-27
Neurosurgical Outcome Network
Aneurysms, Arteriovenous Malformations
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta45002022-12-052026-03-30
Normal Pressure Hydrocephalus Biomarkers Investigation
Measurement of oxysterol profile, including 20 molecules, in liquor before and after surgery - Normal Pressure Hydrocephalus, Cognitive Impairment
UnknownUniversity of Roma La Sapienza302022-10-302022-10-03
Study of Changes in CSF Ionic Composition After Aneurysmal Meningeal Hemorrhage
Concurrent evaluation of blood and CSF ionograms to determine if there is a correlation between CSF change and the development of hyoponatremia between day 0 and day 14. - Subarachnoid Hemorrhage
UnknownHospices Civils de Lyon802022-10-012023-07-12
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
eShunt Implant - Hydrocephalus, Normal Pressure, Hydrocephalus
Not applicableActive not recruitingCereVasc Inc502022-04-202025-06-19
The Effects of Exercise on Gait Characteristics, Balance, and Performance in Patients With Normal Pressure Hydrocephalus
Exercise Program - NPH (Normal Pressure Hydrocephalus)
Not applicableCompletedDokuz Eylul University412022-04-072026-10-05
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
eShunt Implant - Hydrocephalus, Normal Pressure, Hydrocephalus
Not applicableActive not recruitingCereVasc Inc302022-03-102026-03-18
Acetazolamide Trial in Normal Pressure Hydrocephalus
Acetazolamide, Placebo - Idiopathic Normal Pressure Hydrocephalus (INPH)
Phase 2CompletedUppsala University Hospital502022-02-172026-05-06
The Role of the Glymphatic System Avaluated Thourgh mr Imaging in the Diagnosis and Management of NPH
Hydrocephalus, Normal Pressure Hydrocephalus
CompletedFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta292021-06-152026-02-11

Showing 20 of 63. Sign in to see all of them.

Narrower conditions

Hydrocephalus (21)  ·  Dementia (5)  ·  Alzheimer Disease (3)  ·  Parkinson Disease (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cognitive Dysfunction (2)  ·  Frontotemporal Dementia (2)  ·  Mobility Limitation (2)  ·  Multiple System Atrophy (2)  ·  Parkinsonian Disorders (2)  ·  Plaque, Amyloid (2)  ·  Pseudotumor Cerebri (2)  ·  Subarachnoid Hemorrhage (2)

Broader conditions

Nervous System Diseases (62)  ·  Brain Diseases (61)  ·  Central Nervous System Diseases (61)  ·  Hydrocephalus (42)  ·  Mental Disorders (14)  ·  Neurocognitive Disorders (12)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Neurodegenerative Diseases (7)  ·  Signs and Symptoms (7)  ·  Dementia (5)  ·  Movement Disorders (5)  ·  Basal Ganglia Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Neurologic Manifestations (4)  ·  Pathologic Processes (4)

Interventions

Ventriculoperitoneal Shunt (4)  ·  Acetazolamide (2)  ·  Hydrodynamics (2)  ·  Spinal Puncture (2)  ·  Ventriculostomy (2)  ·  flutemetamol (2)  ·  Cerebrovascular Circulation (1)  ·  Control Groups (1)  ·  Fluorescent Antibody Technique (1)  ·  Immunohistochemistry (1)  ·  Occupational Therapy (1)  ·  Physical Therapy Modalities (1)  ·  Physicians, Primary Care (1)  ·  Resistance Training (1)  ·  Speech Therapy (1)

Sponsors

Umeå University (5)  ·  CereVasc Inc (3)  ·  Johns Hopkins University (3)  ·  Centre Hospitalier Universitaire, Amiens (2)  ·  Codman & Shurtleff (2)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (2)  ·  GE Healthcare (2)  ·  Integra LifeSciences Corporation (2)  ·  NeuroDx Development (2)  ·  University Hospital Hradec Kralove (2)  ·  University of South Florida (2)  ·  University of Valencia (2)  ·  Vanderbilt University Medical Center (2)  ·  Assiut University (1)  ·  Chungnam National University Hospital (1)

Countries

United States (21)  ·  Sweden (10)  ·  France (5)  ·  Germany (4)  ·  Italy (4)  ·  Czechia (3)  ·  Spain (3)  ·  Argentina (2)  ·  Denmark (2)  ·  Finland (2)  ·  Israel (2)  ·  Netherlands (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Belgium (1)

Top investigators

Jan Malm, MD, PhD (2)  ·  Johan Virhammar, MD, PhD (2)  ·  Kim A Mansfield, MS (2)  ·  Miroslav Cihlo, M.D. (2)  ·  Naomi Abel, MD (2)  ·  Anders Behrens, M.D., M.Sc. (1)  ·  Anthony Marmarou, Ph.D. (1)  ·  Carine W. Maurer, MD, PhD (1)  ·  Carsten I Wikkelsoe, MD (1)  ·  Clemens MF Dirven, Prof. PhD (1)  ·  DaiWai Olson, PhD, RN, CCRN, FNCS (1)  ·  Daniele Rigamonti, MD (1)  ·  Daniele Rigamonti, MD FACS (1)  ·  Daniele Rigamonti, MD, FACS (1)

Results publications

PMID 20097391, PMID 40135887, PMID 41734937, PMID 1114545, PMID 18092331, PMID 18092336, PMID 18282655, PMID 18402070, PMID 19388301, PMID 19713705, PMID 20404696, PMID 21660204, PMID 22038765, PMID 23250963, PMID 23415160, PMID 23510566, PMID 24118122, PMID 24379955, PMID 24729303, PMID 25279138, PMID 26003249, PMID 26578001, PMID 27490149, PMID 28486988, PMID 28889317, PMID 28892272, PMID 28919849, PMID 29710721, PMID 30248058, PMID 30738407, PMID 30792248, PMID 31141553, PMID 31167811, PMID 31561378, PMID 31997040, PMID 32747697, PMID 3351510, PMID 33720890, PMID 34093167, PMID 34275898, PMID 34809666, PMID 35164790, PMID 35230552, PMID 35325129, PMID 35418936, PMID 35431542, PMID 35733946, PMID 35901765, PMID 36552981, PMID 37976516

NIH funding

R43NS067770 (1)